Skip to main content
Fig. 2 | BMC Musculoskeletal Disorders

Fig. 2

From: Prevention of glucocorticoid-associated osteonecrosis by intravenous administration of mesenchymal stem cells in a rabbit model

Fig. 2

Western blotting of in each organ administered GFP-labeled MSC. Expression of GFP-labeled MSC in each organ (a, b). MSC(+)/MP(+)/3d (a). MSC(+)/MP(−)/3d (b). Comparison of MSC(+)/MP(+)/3d and MSC(+)/MP(−)/3d in femur (c). In MSC(+)/MP(−)/3d there was no expression of GFP-labeled MSC in femur or any organ, while in MSC(+)/MP(+)/3d GFP-labeled MSC expression was not found in any organ but was significantly present in femur

Back to article page